Fujian issued its '15th Five‑Year' Health Development Plan, prioritizing deeper
cross‑strait health integration and cross‑regional openness. The plan backs
construction of cross‑strait biotechnology and medical‑health industry
cooperation zones, promotes cooperation with Taiwan in biopharma R&D,
major‑disease prevention and frontier medical technology, encourages
introduction of Taiwan‑listed, high‑clinical‑value innovative drugs and devices
into Fujian medical institutions, and supports Fujian University of Traditional
Chinese Medicine in establishing a cross‑strait integrated TCM key laboratory.